Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Shares Outstanding (Entity) of $42.9 million for Q3 2025, up 45.93% year-over-year from $29.4 million in Q3 2024, and up 33.19% quarter-over-quarter from $32.2 million in Q2 2025.
Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $42.9 million for Q3 2025.
- In Q3 2025, Shares Outstanding (Entity) rose 45.93% year-over-year to $42.9 million; the TTM figure through Sep 2025 stood at $42.9 million (up 45.93% YoY), while the FY2024 annual figure was $31.1 million, up 503.78% from the prior year.
- Shares Outstanding (Entity) for Q3 2025 stood at $42.9 million, up from $32.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $42.9 million in Q3 2025, with the low at $3.0 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $3.8 million (2023), against an average of $14.3 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) climbed 0.58% in 2022, then jumped 674.31% in 2024.
- Dianthus Therapeutics' Shares Outstanding (Entity) stood at $3.7 million in 2021, then advanced by 3.13% to $3.8 million in 2022, then surged by 35.97% to $5.2 million in 2023, then surged by 503.78% to $31.1 million in 2024, then soared by 37.73% to $42.9 million in 2025.
- Business Quant data shows DNTH's Shares Outstanding (Entity) at $42.9 million in Q3 2025, $32.2 million in Q2 2025, and $32.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | 37.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.79 Mn |
| Sep 30, 2025 | 37.79 Mn |
| Jun 30, 2025 | 35.82 Mn |
| Mar 31, 2025 | 35.79 Mn |
| Dec 31, 2024 | 33.31 Mn |
| Sep 30, 2024 | 34.24 Mn |
| Jun 30, 2024 | 34.23 Mn |
| Mar 31, 2024 | 25.67 Mn |
| Dec 31, 2023 | 5.15 Mn |
| Sep 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.79 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.71 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 3.68 Mn |
| Mar 31, 2022 | 3.67 Mn |
| Dec 31, 2021 | 3.43 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 3.04 Mn |